Researchers at University of Sydney have found that cholesterol lowering drugs are beneficial even to those who have a low risk of heart attack.

Stating that the new evidence suggests there is a necessity to make changes in the guidelines, writing in The Medical Journal of Australia, the researchers said, “While there is no substitute for lifestyle modification, the capacity for statin pharmacotherapy to assist in the treatment of individuals at lower risk has now been shown. This new evidence must be urgently considered, with appropriate economic analyses, for incorporation into clinical and PBS [Pharmaceutical Benefits Scheme] guidelines.”
Source-Medindia